Variability of neuromuscular transmission in myasthenia gravis.
D000200:Action Potentials; D000690:Amyotrophic Lateral Sclerosis / Q000503:physiopathology; D001906:Botulism / Q000503:physiopathology; D001984:Bronchial Neoplasms / Q000503:physiopathology; D002277:Carcinoma / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004558:Electric Stimulation; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D009132:Muscles / Q000503:physiopathology*; D009135:Muscular Diseases / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000503:physiopathology*; D009410:Nerve Degeneration; D010525:Peripheral Nerves / Q000503:physiopathology*; D010523:Peripheral Nervous System Diseases / Q000503:physiopathology; D009435:Synaptic Transmission
D002800:Cholinesterase Inhibitors; D005938:Glucocorticoids